On September 27, 2016, FDA is conducting a public meeting on Patients Who Have Received an Organ Transplant. FDA is interested in obtaining patient input on the impact of receiving an organ transplant on daily life and patients’ views on currently available therapies to manage organ transplantation.
This website will be updated as meeting materials are developed.
September 27, 2016
9:00 a.m. - 5:00 p.m.
FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Room 1503A (Great Room)
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)
Access the public docket here: Docket information
Meeting Report (PDF - 400 KB)
Meeting Agenda (PDF - 221KB)
- Webinar: Background on FDA and Patient-Focused Drug Development
- Meeting Slides
- Meeting Recording 1
- Meeting Recording 2
- Meeting Recording 3
- Meeting Recording 4